Continuous infusion of vancomycin in critically ill patients: A new trend?;Vers la perfusion continue de vancomycine en reanimation?

Medecine et Maladies Infectieuses

Volumn 27, Issue SPEC. ISS. NOV., 1997, Pages 962-964

  Wysocki, M ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Antibiotherapy; Continuous infusion of vancomycin; Cost efficacy; Methicillin resistant staphylococcal infection; Monitoring; Nephrotoxicity; Vancomycin

Indexed keywords

VANCOMYCIN;

ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICAL ILLNESS; DRUG EFFICACY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0031438755     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(97)80197-7     Document Type: Article

References (19)

1. Geraci J.E. Heilman F.R. Nichols D.R. Wellman W.E. Ross G.T. Some laboratory and clinical experiences with a new antibiotic, vancomycin Proc Staff Meet Mayo Clin 31 1956 564 582
2. Kirby W.M.M. Divelbiss C.L. Vancomycin: clinical and laboratory studies Welch H. Marti-Ibanez F. Antibiotics annual 1956–1957 1957 New-York Medical Encyclopedia Baltimore 107 117
3. Prins J.M. Büller H.R. Kuijper E.J. Tange R.A. Speelman P. Once versus thrice daily gentamycin in patients with serious infections Lancet 341 1993 335 339
4. Arnette Regnier B. Garaud J.J. Wolff M. Laisné M.J. Rouveix E. Nkam M. Vachon F. La vancomycine seule et en association aux aminosides Vachon F. Regnier B. Problèmes actuels de pathologie infectieuse et de réanimation 1984 119 131
5. Levine D.P. Fromm B.S. Reddy B.R. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis Ann Intern Med 115 1991 674 680
6. Barois A. Estounet B. Moranne J.B. Piliot J. Chabenat C. Bataille J. Infections ventriculaires à staphylocoque. Traitement par la vancomycine en perfusion continue Presse Med 15 1986 1805 1808
7. Goulet O. Larchet M. Gaillard J.L. Goulet V. Jan D. Revillon Y. Lortat-Jacob S. Descamps P. Ricour C. Catheter related sepsis during long-term parenteral nutrition in paediatric gastroenterology patients: a study of 185 consecutive central venous catheters Clin Nutrit 9 1990 73 78
8. Thomas F. Michel P. Ravaud Y. Traitement d'infections à staphylocoque chez l'adulte par perfusion continue de vancomycine en monothérapie Sem Hôp Paris 64 1988 215 218
9. Brinquin L. Rousseau J.M. Boulesteix G. Diraison Y. Bonsignour J.P. Vancomycine en perfusion continue dans les méningites à staphylocoques post-neurochirurgicales de l'adulte Presse Med 22 1993 1815 1817
10. Longuet P. Vallée E. Michel M. Peronne C. Janvier M. Leport C. Vildé J.L. Vancomycine dans les méningites à Streptococcus pneumoniae résistant à la pénicilline G Presse Med 22 1993 1818 1819
11. Conil J.M. Favarel H. Laguerre J. Brouchet A. Chabanon G. Cazal L. Bodnar M. Rougé D. Virenque C. Costagliola M. Vancomycine en administration continue chez le grand brûlé Presse Med 23 1994 1554 1558
12. Duffull S.B. Begg E.J. Chambers S.T. Barclay M.L. Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with dynamic in vitro model Antimicrob Agents Chemother 38 1994 2480 2482
13. James J.K. Palmer S.M. Levine D.P. Rybak M.J. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented Gram-positive infections Antimicrob Agents Chemother 40 1996 696 700
14. Wysocki M. Thomas F. Wolff M.A. Pean Y. Ravaud Y. Herman B. Comparison of continuous with discontinuous infusion of vancomycin in severe MRSA infections J Antimicrob Chemother 35 1995 352 354
15. o Wysocki M. Wolff M.A. Pean Y. Tric L. Gertner J. Millet H. Herman B. Traitement des infections graves à staphylocoque par perfusion continue de vancomycine : tolérance rénale 1991 RICAI New-York
16. Wysocki M. Pean Y. Delatour F. Rauss A. Thomas F. Misset B. Cheval C. Similowski T. Timsit J.F. Laisne M.J. Mentec H. Lazard T. Mier L. Dreyfuss D. Maury E. Lamer C. Guerrini P. Guérin C. Briard C. Continuous infusion of vancomycin for severe methicillin-resistant staphylococcal infections Intens Care Med 22 1996 S325
17. Wysocki M. Rauss A. Pean Y. Delatour F. Thomas F. Misset B. Cheval C. Similowski T. Timsit J.F. Laisne M.J. Mentec H. Lazard T. Mier L. Dreyfuss D. Tric L. Guerrini P. Briard C. Guérin C. Maury E. The cost of vancomycin therapy in severe methicillin-resistant staphylococcal infections: continuous versus discontinuous infusion Intens Care Med 22 1996 S299 s2
18. Saunders N.J. Why monitor peak vancomycin concentration ? Lancet 344 1994 1748 1750
19. (letter) Wysocki M. Thomas F. Wolff M. Why monitor peak vancomycin concentration ? Lancet 344 1995 646